Microbiotica Ltd
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase 1b Trial to Evaluate the Safety of MB310 in Patients With Active, Mild-to-Moderate Ulcerative Colitis (NCT06582264) | Microbiotica Ltd | 2024-09-27 |
| A Phase 1b Trial to Evaluate Safety of MB097 in Combination With Pembrolizumab in Melanoma Patients (NCT06540391) | Microbiotica Ltd | 2024-08-28 |
Track Microbiotica Ltd automatically
Every clearance here is in the API, with alerts when new ones post.